老虎证券

美股详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Akari Therapeutics PLC

0.8191
+0.00670.82%
盘后：0.81910.00000.00%16:10 EDT
成交量：2.06万
成交额：1.69万
市值：2,671.47万
市盈率：-1.51
高：0.8340
开：0.8201
低：0.8001
收：0.8124
52周最高：3.85
52周最低：0.5714
股本：3,261.47万
流通股本：562.08万
量比：0.03
换手率：0.37%
股息：- -
股息率：- -
每股收益(TTM):-0.5428
每股收益(LYR):-1.6570
净资产收益率：-112.02%
总资产收益率：-28.56%
市净率：1.04
市盈率(LYR):-0.49

数据加载中...

总览公司新闻公告
2023/04/14

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/11/07

SEC问询函

CORRESP [Cover] - Correspondence
2022/11/04

[修订]招股说明书

F-1/A [Amend] - Registration statement for certain foreign private issuers
2022/10/12

招股说明书

F-1 - Registration statement for certain foreign private issuers
2022/05/16

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/14

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/08/30

SEC问询函

CORRESP [Cover] - Correspondence
2021/04/21

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/12/30

SEC问询函

CORRESP [Cover] - Correspondence
2020/11/16

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/08/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/07/24

SEC问询函

CORRESP [Cover] - Correspondence
2020/07/17

招股说明书

F-1 - Registration statement for certain foreign private issuers
2020/07/02

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/04/15

SEC问询函

CORRESP [Cover] - Correspondence
2020/03/31

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/03/31

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
更多